Up next

Autoplay

Oncogene-addicted non-small cell lung cancer

2 Views • 07/14/23
Share
Embed
administrator
administrator
Subscribers
0

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Pasi A. Jänne, MD, PhD, from Dana-Farber Cancer Institute, Boston, MA, discusses the application of the concept “oncogene addiction”, which postulates that a cancer cell exhibits dependence on a single oncogenic pathway or protein for its sustained proliferation or survival, in the development of targeted therapies for non-small cell lung cancer (NSCLC).

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay